Dallas Nephrology Associates to Receive 2026 Burl Osborne Award from the National Kidney Foundation

Audio By Carbonatix

DALLAS--(BUSINESS WIRE)--Mar 10, 2026--

Dallas Nephrology Associates (DNA) is honored to be recognized with the Burl Osborne Award at the National Kidney Foundation’s Bonne Santé 2026 event, taking place on Saturday, March 7, 2026. The award celebrates exceptional philanthropic and corporate leadership in raising awareness about kidney disease and advancing the mission of the National Kidney Foundation (NKF).

DNA exemplifies a longstanding commitment to kidney health through patient education, community engagement, and fundraising initiatives across North Texas and Oklahoma. This recognition highlights DNA’s dedication to improving kidney health outcomes and supporting the NKF’s initiatives to educate and empower patients.

“The Burl Osborne Award is one of the highest honors the National Kidney Foundation bestows,” said Dr. Alexander Liang, CEO and President of Dallas Nephrology Associates. “We are proud to continue our partnership with the NKF and to support their mission of raising awareness and advancing care for kidney disease patients.” Dr. Liang will be onsite to receive the award during the event.”

Established in 2012, the Burl Osborne Award honors the late Burl Osborne, former NKF board member and publisher of The Dallas Morning News, who was an early recipient of a living-donor kidney transplant. The award recognizes individuals and organizations that have made significant contributions to kidney disease awareness, education, and organ donation advocacy.

“What truly distinguishes Dallas Nephrology Associates is the spirit of service that runs through their entire organization,” said Calvin Lyons, NKF Executive Director. “Their physicians, staff, and supporters show up every single year—not only in remarkable numbers, but with a deep and genuine commitment to improving outcomes for the kidney community. Their leadership has made a lasting difference.”

Dallas Nephrology Associates previously received the Burl Osborne Award in 2014, further demonstrating their ongoing commitment to the cause. For more information about the event and to support the NKF, visit: NKF Bonne Santé 2026.

About Dallas Nephrology Associates
Established in 1971, Dallas Nephrology Associates (DNA), has been at the forefront of creating person-centered value-based care in Nephrology, with a focus on innovation and patient choice. For over 50 years, DNA has been a trusted source of information and education resulting in quality kidney care. DNA offers the entire spectrum of nephrology care from the office management of CKD patients, to 24/7 coverage of hospitals, dialysis clinics, as well as management of the dialysis accesses of dialysis patients through our 2 vascular centers in the Dallas Fort Worth Metroplex.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260310955059/en/

CONTACT: Media Contact:

Margulies Communications Group

214-368-0909

[email protected]

KEYWORD: TEXAS UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: OTHER PHILANTHROPY MANAGED CARE GENERAL HEALTH HEALTH HOSPITALS PHILANTHROPY FOUNDATION OTHER HEALTH

SOURCE: Dallas Nephrology Associates

Copyright Business Wire 2026.

PUB: 03/10/2026 03:36 PM/DISC: 03/10/2026 03:36 PM

http://www.businesswire.com/news/home/20260310955059/en